Reprint

The Tumor Microenvironment of High Grade Serous Ovarian Cancer

Edited by
February 2019
434 pages
  • ISBN978-3-03897-554-0 (Paperback)
  • ISBN978-3-03897-555-7 (PDF)

This book is a reprint of the Special Issue The Tumor Microenvironment of High Grade Serous Ovarian Cancer that was published in

Biology & Life Sciences
Medicine & Pharmacology
Summary

The Special Issue on high grade serous ovarian cancer (HGSOC) and the contribution of the tumor microenviroment (TME) consists of reviews contributed by leaders in the OC field. As HGSOC metastases have a highly complex TME, there is an urgent need to better understand the TME in general, its distinct components in particular, and the role of the TME in the context of disease recurrence and development of chemoresistance. The Special Issue incorporates the current understanding of the different parts of thd TME components, including the cancer cells themselves, the cells surrounding the cancer cells or stromal cells, and the cells of the immune system, which are attracted to the site of metastases.  In addition to these cells of the TME, the role of various cellular factors  made by the cells of the TME are also  the subject of the reviews. In addition, reviews in this Special Issue cover the complex relationships between the molecular mechanisms of HGSOC progression, including genomic, epigenomic and transcriptomic changes and changes in the immune cell landscape, as these may provide attractive new molecular targets for HGSOC therapy.

Format
  • Paperback
License
© 2019 by the authors; CC BY-NC-ND license
Keywords
lipids; lysophospholipids (LPLs); lysophosphatidic acid (LPA); sphingosine-1-phosphate; tumor microenvironment (TME); epithelial ovarian cancer (EOC); ovarian cancer; age; tumor microenvironment; extracellular matrix; mesothelial cells; immune; fibroblast; adipocytes; peritoneum; ovarian cancer; cancer stem cells; signaling; chemoresistance; metastasis; epithelial ovarian cancer; tumor microenvironment; tumor infiltrating lymphocytes; tumor-associated antigens; ascites; immunosuppression; prognostic factors; cancer-associated fibroblasts; exosomes; adipocytes; ovarian cancer; tumor microenvironment; immune infiltrating cells; chemotherapy; immunotherapy; syngeneic; transgenic models; hot vs. cold tumors; immunosuppression; inflammation; epithelial ovarian cancer; cytokines; reactive oxygen species; growth factors; ovarian cancer; endometriosis; tumor microenvironment; miRNA molecules; genes; hypoxia; inflammation; model systems; high-grade serous ovarian carcinoma (HGSC); PAX2; PAX8; cell of origin; ovary; fallopian tube; ovarian cancer; tumor microenvironment; 3D models; high-grade serous ovarian cancer; tumor microenvironment; angiogenesis; immune response; metastasis; therapeutic targeting strategies; ovarian cancer; mesothelin; CA125; tumor microenvironment; ovarian cancer; epigenetics; tumor microenvironment; DNA methylation; histone modifications; chromatin remodeling; non-coding RNAs; ovarian cancer; heated intraperitoneal chemotherapy (HIPEC); intraperitoneal chemotherapy (IP); cytoreductive surgery; secondary cytoreduction; interval cytoreduction; tumor microenvironment; immune inhibition; tumor-infiltrating lymphocytes; tumor-associated macrophages; dendritic cells; antitumor immunity; immunotherapy; high grade serous ovarian cancer; metabolism; mitochondria; oxidative phosphorylation; oxidative stress; biguanides; atovaquone; plumbagin; thiazolidinediones; ubiquinone; Nrf-2; Rho-GTPase; Rac1; guanine nucleotide exchange factors (GEFs); GTPase activating proteins (GAPs); oncogene; oncoprotein; ovarian cancer; tumor microenvironment; bone niche; therapeutic targeting; ovarian cancer; tumor-associated macrophages; peritoneal metastasis; tumor microenvironment; ovarian cancer; tumor microenvironment; cancer associated fibroblasts; fibroblast; cross-talk; invasion; angiogenesis; ECM; chemoresistance; therapy; ovarian cancer; epithelial ovarian cancer; high-grade serous ovarian cancer (HGSOC); high-grade serous carcinoma (HGSC); ovarian cancer origin; fallopian tube; ovarian surface epithelium (OSE); serous tubal intraepithelial carcinoma (STIC); ovarian cancer; organ-specific metastases; peritoneal adhesion; mesothelium; omentum; peritoneal wall; lymph node; liver; lung; gene expression; n/a